Validity of the Musculoskeletal Tumor Society Score for lower extremity in patients with bone sarcoma or giant cell tumour of bone undergoing bone resection and reconstruction surgery in hip and knee

Nikolai Sherling, Müjgan Yilmaz, Christina Holm, Michael Mørk Petersen, Linda Maria Fernandes

Publikation: Bidrag til tidsskriftTidsskriftsartikelForskningpeer review

Abstract

Background The Musculoskeletal Tumor Society Score (MSTS) is widely used to evaluate functioning following surgery for bone and soft-tissue sarcoma. However, concerns have been raised about its content validity due to the
lack of patient involvement during item development. Additionally, literature reports inconsistent results regarding data quality and structural validity. This study aimed to evaluate content, structural and construct validity of the
Danish version of the MSTS for lower extremity (MSTS-LE).
Methods The study included patients from three complete cohorts (n = 87) with bone sarcoma or giant cell tumour of bone who underwent bone resection and reconstruction surgery in hip and knee. Content validity was evaluated
by linking MSTS items to frameworks of functioning, core outcome sets and semi-structured interviews. Data quality, internal consistency and factor analysis were used to assess the underlying structure of the MSTS. Construct validity was based on predefined hypotheses of correlation between the MSTS and concurrent measurements.
Results Content validity analysis revealed concerns regarding the MSTS. The MSTS did not sufficiently cover patientimportant
functions, the item Emotional acceptance could not be linked to the framework of functioning, the items Pain and Emotional acceptance pertained to domains beyond functioning and items’ response options did not match items. A two-factor solution emerged, with the items Pain and Emotional acceptance loading highly on a second factor distinct from functioning. Internal consistency and construct validity showed values below accepted levels.
Conclusion The Danish MSTS-LE demonstrated inadequate content validity, internal consistency, and construct validity. In addition, our analyses did not support unidimensionality of the MSTS. Consequently, the MSTS-LE is not
a simple reflection of the construct of functioning and the interpretation of a sum score is problematic. Clinicians and researcher should exercise caution when relying solely on MSTS scores for assessing lower extremity function.
OriginalsprogEngelsk
Artikelnummer1019
TidsskriftBMC Cancer
Vol/bind24
Udgave nummer1
Antal sider11
ISSN1471-2407
DOI
StatusUdgivet - dec. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Validity of the Musculoskeletal Tumor Society Score for lower extremity in patients with bone sarcoma or giant cell tumour of bone undergoing bone resection and reconstruction surgery in hip and knee'. Sammen danner de et unikt fingeraftryk.

Citationsformater